Home / Current Issue / Paper 1709521
Barriers and Facilitators to COVID-19 Vaccine Uptake Among the Elderly
Subject area: Biological & Medical Sciences · Area of research: Kiambu County, Kenya
Abstract
Introduction: Globally as of 23rd October 2023,13.5 billion doses of COVID-19 vaccine had been administered. In Africa, it is estimated that 51.8% of the total population was vaccinated while in Kenya only 27% of the eligible population was fully vaccinated. Vaccination is the mainstay of healthcare policy and a crucial element in preventing infectious diseases. The study aimed to determine the barriers and facilitators to COVID-19 vaccine uptake among the elderly. Study Objective: To identify the barriers and facilitators to COVID-19 vaccine uptake among the elderly in Kiambu County. Methodology: A community-based cross-sectional study was undertaken in several sub-counties in Kiambu County. A multistage cluster sampling method was used to recruit 423 participants for this study. The participants were given informed consent. An interviewer-administered questionnaire and key informant interviews were used to collect data. Multivariate logistic regression was used to determine the predictors of COVID-19 vaccine uptake among the elderly. Results: In total, 423 participants aged 60 years and above were considered in this study, 58.6% were female. Most of the participants (90%) were aware of the COVID-19 vaccine. The level of uptake of COVID-19 vaccine was 55.8%. The most common reason for taking up the vaccine was because it was free (84.3%). The statistically significant facilitators were fear of getting COVID-19, OR 0.234(95% 0.056-0.974, p-value 0.046), trusting that the COVID-19 vaccine is effective OR 0.131 (95% 0.031-0.553, p-value 0.006), being not afraid of side effects of the vaccine OR 6.872 (95% 3.651-12.938 p-value 0.000), and believing that the vaccine is safe OR 0.098 (95% 0.024-0.398, p-value 0.001). The barriers to COVID-19 vaccine uptake were, that vaccinated people were still getting infected (70.1%), having to walk a longer distance to the vaccination center,19 minutes vs 23 minutes, p=0.010 and fear of side effects (p=0.003). Conclusion: 55.8% of the participants have already received COVID-19 vaccine. The major barriers to COVID-19 vaccine uptake were fear of side effects, restricted access to immunization facilities and vaccine apathy. Perceived severity, perceived susceptibility, and perceived benefits were major facilitators of COVID-19 vaccine uptake.
Keywords
COVID-19 vaccine uptake, elderly, barriers to vaccination, facilitators of vaccine uptake
References
[1] World Health Organization, "WHO COVID-19 Dashboard," 12 May 2024. [Online]. Available: https://data.who.int/dashboards/covid19/deaths?n=o. [Accessed 29 May 2024].
[2] Ngere, Philip, "Characterization of COVID-19 cases in the early phase (March to July 2020) of the pandemic in Kenya," Global health, vol. 12 15001, 2022.
[3] WHO, "COVID-19 vaccination, World data," WHO, 31 December 2023. [Online]. Available: https://data.who.int/dashboards/covid19/vaccines?n=o. [Accessed 29 May 2024].
[4] CDC, "Latest updates from Africa CDC on progress made in COVID-19 vaccinations on the continent," Africa CDC, 2024. [Online]. Available: https://africacdc.org/covid-19-vaccination/. [Accessed 29 May 2024].
[5] WHO, "WHO Africa," 6 March 2021. [Online]. Available: https://www.afro.who.int/news/kenya-receives-covid-19-vaccines-and-launches-landmark-national-campaign. [Accessed 2024 May 2024].
[6] Kyobutungi, Catherine, "African Population and Health Research Center," 8 April 2021. [Online]. Available: https://aphrc.org/blogarticle/kenyas-covid-19-vaccine-rollout-has-got-off-to-a-slow-start-the-gaps-and-how-to-fix-them/. [Accessed 5 29 2024].
[7] Xing, Kai, "Efficacy and safety of COVID-19 vaccines: a systematic review," Chinese journal of contemporary pediatrics, vol. 23(3), p. 221–228, 2021.
[8] Kenya National Bureau of Statistics, "2019 Kenya Population and Housing Census Volume III :Distribution of population by age and sex," Kenya National Bureau of Statistic (knbs.or.ke), 2019.
[9] Anino C.O,Wandera, I., Masimba, Z. O., Kirui, C. K., Makero, C. S., Omari, P. K., & Sanga, P, "Determinants of Covid-19 vaccine uptake among the elderly aged 58 years and above in Kericho County, Kenya," PLOS global public health vol. 3,9 e0001562. 12 Sep. 2023, Vols. 3,9 e0001562, 2023.
[10] World Health Organization, "Achieving 70% COVID-19 Immunization Coverage by Mid-2022," 23 December 2021. [Online]. Available: https://www.who.int/news/item/23-12-2021-achieving-70-covid-19-immunization-coverage-by-mid-2022. [Accessed 2024 May 2024].
[11] Marta Malesza, Magdalena Bozym, "Factors influencing COVID-19 vaccination uptake in an elderly sample in Poland," medRxiv, p. 2021.03.21.21254047, 2021.
[12] Adedeji-Adenola, H., Olugbake, O. A., & Adeosun, S. A., "Factors influencing COVID-19 vaccine uptake among adults in Nigeria.," PLoS ONE, vol. 17, no. 2 February, pp. 1-12, 2022.
[13] Intan Putri, Hari Purnomo, "The determining factors of COVID-19 vaccination uptake among elderly in Indonesia," International Journal of Public Health Sciences (IJPHS), vol. 11, no. 2, pp. 713-723, 2022.
[14] Grace Frempong Afrifa-Anane ,Reuben Tete Larbi ,Bright Addo ,Martin Wiredu Agyekum ,Frank Kyei-Arthur ,Margaret Appiah ,Clara Opoku Agyemang ,Ignatius Great Sakada, "Facilitators and barriers to COVID-19 vaccine uptake among women in two regions of Ghana: A qualitative study," PLOS ONE, vol. 17, no. 8 August, pp. 1-17, 2022.
[15] Badr, H., Zhang, X., Oluyomi, A., Woodard, L. D., Adepoju, O. E., Raza, S. A., & Amos, C. I. , "Overcoming COVID-19 Vaccine Hesitancy: Insights from an Online Population-Based Survey in the United States.," Vaccines, vol. 9, no. 10, pp. 1-17, 2021.
[16] Anggraeni Puspasari; Anhari Achadi, Pendekatan health belief model untuk menganalisis penerimaan vaksinasi covid-19 oleh masyarakat Indonesia = The use of the health belief model to assess acceptance to receive the covid-19 vaccine in Indonesia., vol. 3, Tanah Bumbu: University of Indonesia Library, 2022, pp. 27-37.
How to cite this paper
@article{1709521,
author = {Josephine Ndulu Mutisya, Joseph Mwangi Thigiti, Osborn Tembu},
title = {Barriers and Facilitators to COVID-19 Vaccine Uptake Among the Elderly},
journal = {Iconic Research And Engineering Journals},
year = {2025},
volume = {9},
number = {1},
pages = {143-150},
issn = {2456-8880},
url = {https://www.irejournals.com/formatedpaper/1709521.pdf},
abstract = {Introduction:
Globally as of 23rd October 2023,13.5 billion doses of COVID-19 vaccine had been administered. In Africa, it is estimated that 51.8% of the total population was vaccinated while in Kenya only 27% of the eligible population was fully vaccinated. Vaccination is the mainstay of healthcare policy and a crucial element in preventing infectious diseases. The study aimed to determine the barriers and facilitators to COVID-19 vaccine uptake among the elderly.
Study Objective: To identify the barriers and facilitators to COVID-19 vaccine uptake among the elderly in Kiambu County.
Methodology: A community-based cross-sectional study was undertaken in several sub-counties in Kiambu County. A multistage cluster sampling method was used to recruit 423 participants for this study. The participants were given informed consent. An interviewer-administered questionnaire and key informant interviews were used to collect data. Multivariate logistic regression was used to determine the predictors of COVID-19 vaccine uptake among the elderly.
Results: In total, 423 participants aged 60 years and above were considered in this study, 58.6% were female. Most of the participants (90%) were aware of the COVID-19 vaccine. The level of uptake of COVID-19 vaccine was 55.8%. The most common reason for taking up the vaccine was because it was free (84.3%). The statistically significant facilitators were fear of getting COVID-19, OR 0.234(95% 0.056-0.974, p-value 0.046), trusting that the COVID-19 vaccine is effective OR 0.131 (95% 0.031-0.553, p-value 0.006), being not afraid of side effects of the vaccine OR 6.872 (95% 3.651-12.938 p-value 0.000), and believing that the vaccine is safe OR 0.098 (95% 0.024-0.398, p-value 0.001). The barriers to COVID-19 vaccine uptake were, that vaccinated people were still getting infected (70.1%), having to walk a longer distance to the vaccination center,19 minutes vs 23 minutes, p=0.010 and fear of side effects (p=0.003).
Conclusion: 55.8% of the participants have already received COVID-19 vaccine. The major barriers to COVID-19 vaccine uptake were fear of side effects, restricted access to immunization facilities and vaccine apathy. Perceived severity, perceived susceptibility, and perceived benefits were major facilitators of COVID-19 vaccine uptake.},
keywords = {COVID-19 vaccine uptake, elderly, barriers to vaccination, facilitators of vaccine uptake},
month = {July},
}